Acadia Pharmaceuticals reported $16K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
ALKERMES ALKS:US USD 1.69M 1000
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Aptinyx Inc APTX:US USD 677K 0
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bristol Myers Squibb BMY:US USD 292M 0
Cara Therapeutics CARA:US USD 53K 0
Corcept Therapeutics CORT:US USD 130K 2K
Cytokinetics CYTK:US USD 93K 8K
Eisai 4523:JP JPY 44.99B 0
Eli Lilly And LLY:US USD 594.1M 0
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Intra Cellular Therapies ITCI:US USD 9K 0
Marinus Pharmaceuticals MRNS:US USD 37K 0
Moderna Inc MRNA:US USD 38.7K 500
Neurocrine Biosciences NBIX:US USD 100K 0
Ptc Therapeutics PTCT:US USD 71K 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 185K 1000
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vanda Pharmaceuticals VNDA:US USD 57K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
YTE INCY:US USD 222K 0